ADCY2 Antikörper (Middle Region)

Produktnummer ABIN928275

Dieser Anti-ADCY2-Antikörper ist ein Kaninchen-Polyklonal-Antikörper zum Nachweis von ADCY2 in WB. Geeignet für Human.

Kurzübersicht für ADCY2 Antikörper (Middle Region) (ABIN928275)

Target: ADCY2 (Adenylate Cyclase 2 (Brain) (ADCY2))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ADCY2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-ADCY2 Antikörper

Bindungsspezifität: Middle Region

Aufreinigung: Purified

Immunogen: ADCY2 antibody was raised in rabbit using the middle region of ADCY2 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

ADCY2 Blocking Peptide, (ABIN938373), is also available for use as a blocking control in assays to test for specificity of this ADCY2 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu ADCY2

Target: ADCY2 (Adenylate Cyclase 2 (Brain) (ADCY2))

Andere Bezeichnung: ADCY2

Hintergrund: This gene encodes a member of the family of adenylate cyclases, which are membrane-associated enzymes that catalyze the formation of the secondary messenger cyclic adenosine monophosphate (cAMP). This enzyme is insensitive to Ca(2+)/calmodulin, and is stimulated by the G protein beta and gamma subunit complex. Synonyms: Polyclonal ADCY2 antibody, Anti-ADCY2 antibody, adenylate cyclase 2, brain antibody, AC2 antibody, FLJ16822 antibody, FLJ45092 antibody, HBAC2 antibody, KIAA1060 antibody, MGC133314 antibody.

Pathways: EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma